Get the Stockscreener App
9.04
1.74%
-0.16
After Hours:
9.04
Nurix Therapeutics Inc stock is traded at $9.04, with a volume of 885.40K.
It is down -1.74% in the last 24 hours and down -9.78% over the past month.
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.
See More
Previous Close:
$9.20
Open:
$9.12
24h Volume:
885.40K
Relative Volume:
1.10
Market Cap:
$691.10M
Revenue:
$54.55M
Net Income/Loss:
$-193.57M
P/E Ratio:
-3.128
EPS:
-2.89
Net Cash Flow:
$-181.86M
1W Performance:
-8.78%
1M Performance:
-9.78%
6M Performance:
-37.83%
1Y Performance:
-61.65%
1-Day Range:
$8.86
$9.225
1-Week Range:
$8.86
$10.13
52-Week Range:
$8.18
$29.56
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Name
Nurix Therapeutics Inc
Sector
Industry
Phone
(415) 660-5320
Address
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Compare NRIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
9.04 | 684.22M | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-25 | Initiated | Leerink Partners | Market Perform |
| Dec-10-24 | Initiated | BTIG Research | Buy |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Oct-24-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | Jefferies | Buy |
| Sep-06-24 | Resumed | Robert W. Baird | Outperform |
| Jul-31-24 | Initiated | Truist | Buy |
| Jun-26-23 | Resumed | Oppenheimer | Outperform |
| Mar-09-23 | Initiated | Barclays | Overweight |
| Feb-28-23 | Initiated | Oppenheimer | Outperform |
| Oct-11-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-31-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Feb-10-22 | Initiated | Wells Fargo | Equal Weight |
| Dec-29-21 | Initiated | H.C. Wainwright | Buy |
| Oct-14-21 | Initiated | SVB Leerink | Outperform |
| Jun-04-21 | Resumed | Robert W. Baird | Outperform |
| Apr-30-21 | Resumed | Piper Sandler | Overweight |
| Apr-30-21 | Initiated | RBC Capital Mkts | Outperform |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Nov-19-20 | Initiated | Robert W. Baird | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
| Aug-18-20 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | Piper Sandler | Overweight |
| Aug-18-20 | Initiated | Stifel | Buy |
View All
Nurix Therapeutics Inc Stock (NRIX) Latest News
Nurix Therapeutics (NASDAQ:NRIX) Shares Down 6.5%Here's Why - MarketBeat
Transcript : Nurix Therapeutics, Inc. Presents at Baird Global Healthcare Conference 2025, Sep-09-2025 10 - MarketScreener
Nurix Therapeutics, Inc. $NRIX Shares Sold by Cinctive Capital Management LP - MarketBeat
Parkman Healthcare Partners LLC Sells 181,752 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Transcript : Nurix Therapeutics, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-10-2025 07 - MarketScreener
Nurix Therapeutics : investor deck Baird - MarketScreener
Nurix Therapeutics : investor deck HCW Final - MarketScreener
Vestal Point Capital LP Boosts Stake in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Does Nurix Therapeutics Inc. have a sustainable dividendWeekly Trade Summary & Step-by-Step Swing Trade Plans - beatles.ru
Invesco Ltd. Purchases 65,655 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Combining machine learning predictions for Nurix Therapeutics Inc.Quarterly Portfolio Report & Proven Capital Preservation Methods - Newser
Applying Elliott Wave Theory to Nurix Therapeutics Inc.Long Setup & Risk Controlled Daily Trade Plans - Newser
Does Nurix Therapeutics Inc. show high probability of reboundRisk Management & Daily Risk Controlled Trade Plans - Newser
Using economic indicators to assess Nurix Therapeutics Inc. potentialQuarterly Risk Review & Daily Price Action Insights - Newser
What high frequency data says about Nurix Therapeutics Inc.July 2025 Macro Moves & Smart Allocation Stock Reports - Newser
Market reaction to Nurix Therapeutics Inc.’s recent news2025 Key Lessons & Growth Focused Entry Reports - Newser
Walleye Capital LLC Invests $880,000 in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Applying Wyckoff theory to Nurix Therapeutics Inc. stockMarket Performance Recap & Stock Timing and Entry Methods - Newser
Key resistance and support levels for Nurix Therapeutics Inc.Market Performance Report & Daily Risk Controlled Trade Plans - Newser
Published on: 2025-09-05 13:16:55 - Newser
Is it time to cut losses on Nurix Therapeutics Inc.2025 Market Sentiment & Free Safe Capital Growth Stock Tips - Newser
Will breakout in Nurix Therapeutics Inc. lead to full recoveryJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser
What to do if you’re stuck in Nurix Therapeutics Inc.July 2025 Momentum & Accurate Trade Setup Notifications - Newser
Analyzing Nurix Therapeutics Inc. with multi timeframe chartsMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - Newser
Is this a good reentry point in Nurix Therapeutics Inc.July 2025 Outlook & Daily Entry Point Alerts - Newser
Driehaus Capital Management LLC Sells 563,751 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Analyzing drawdowns of Nurix Therapeutics Inc. with statistical toolsMarket Trend Report & Growth-Oriented Investment Plans - Newser
Sector ETF performance correlation with Nurix Therapeutics Inc.Inflation Watch & Verified Short-Term Trading Plans - Newser
Nuveen LLC Makes New Investment in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics to Discuss Bexobrutideg Developments - The Globe and Mail
Nurix Therapeutics, Inc. $NRIX Shares Sold by Redmile Group LLC - MarketBeat
Tema Etfs LLC Increases Stake in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Understanding Nurix Therapeutics Inc.’s price movementJuly 2025 Catalysts & Detailed Earnings Play Strategies - Newser
Technical signs of recovery in Nurix Therapeutics Inc.2025 Technical Patterns & Precise Buy Zone Identification - Newser
Visual analytics tools that track Nurix Therapeutics Inc. performancePrice Action & Free Technical Confirmation Trade Alerts - Newser
What machine learning models say about Nurix Therapeutics Inc.2025 Price Momentum & High Return Stock Watch Alerts - Newser
Applying big data sentiment scoring on Nurix Therapeutics Inc.2025 Big Picture & Fast Gaining Stock Reports - Newser
Using R and stats models for Nurix Therapeutics Inc. forecastingGold Moves & Short-Term Trading Alerts - Newser
What’s the recovery path for long term holders of Nurix Therapeutics Inc.July 2025 WrapUp & Fast Gain Swing Alerts - Newser
Sentiment analysis tools applied to Nurix Therapeutics Inc.Trade Volume Summary & Weekly Top Gainers Alerts - Newser
Russell Investments Group Ltd. Buys 93,993 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics Inc Stock (NRIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):